Closed
11.3 0.53
24h
Min
11.24
Max
11.31
Income | 19M -31M |
---|---|
Sales | 20M 33M |
EPS | -0.35 |
Profit margin | -94.108 |
Employees | 274 |
EBITDA | 19M -35M |
Recommendations | Buy |
---|---|
12 Months Forecast | +34.34% upside |
Next Earnings | 6 sie 2025 |
---|
Market Cap | 604M 992M |
---|---|
Previous open | 10.77 |
Previous close | 11.3 |
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 15.06 USD 34.34%
High 24 USD
Low 11 USD
Based on 10 Wall Street analysts offering 12 month price targets forVerve Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$